Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Not yet recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed125%
not_yet_recruiting375%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Molecular Characterization of Carbapenemase-Producing Enterobacterales

NCT07116356
not_yet_recruiting

Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients

NCT06709157
not_yet_recruiting

Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospital Acquired Infections in Sohag University Hospitals, Egypt

NCT06628076
completednot_applicable

Molecular Detection of Antibiotic Resistance and H Pylori Eradication

NCT01168063

Clinical Trials (4)

Showing 4 of 4 trials
NCT07116356Not Applicable

Molecular Characterization of Carbapenemase-Producing Enterobacterales

Not Yet Recruiting
NCT06709157

Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients

Not Yet Recruiting
NCT06628076

Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated from Patients with Hospital Acquired Infections in Sohag University Hospitals, Egypt

Not Yet Recruiting
NCT01168063Not Applicable

Molecular Detection of Antibiotic Resistance and H Pylori Eradication

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4